Vera Therapeutics (VERA) Other Operating Expenses (2021 - 2022)
Vera Therapeutics' (VERA) quarterly Other Operating Expenses came in at $16.0 million in Q3 2022, up 492.94% on a QoQ basis from $2.7 million in Q2 2021.
Vera Therapeutics (VERA) Other Operating Expenses (2021 - 2022) Analysis & Trends
Vera Therapeutics (VERA) has 2 years of Other Operating Expenses data on file, last reported at $16.0 million in Q3 2022.
- Quarterly Other Operating Expenses changed N/A year-over-year to $16.0 million in Q3 2022, while the trailing twelve-month figure through Jun 2023 was $16.0 million (changed N/A YoY) and the FY2021 annual result came in at $2.7 million, changed N/A from the prior year.
- Other Operating Expenses rose to $16.0 million in Q3 2022, from $2.7 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $16.0 million in Q3 2022 to a low of $2.7 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Vera Therapeutics | 2.28 Bn | 2.28 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 15.96 Mn |
| Jun 30, 2021 | 2.69 Mn |